Partner/Owner

Representative before the EPO

Employment test 11 - 50 employees
Company dna henkel breuer and partner
operating since 1931
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

We have observed 4 EP applications Markus Breuer has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14755818

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

IPC classification:
A61K 9/28, A61K 31/225
Applicant:
Forward Pharma A/S
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Markus Breuer, Henkel Breuer & Partner
Status:
GRANT OF PATENT INTENDED
EP14755672

PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE

IPC classification:
A61K 9/28, A61K 31/225
Applicant:
Forward Pharma A/S
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Markus Breuer, Henkel Breuer & Partner
Status:
EXAMINATION IN PROGRESS
EP11717240

IMPROVED CELL CULTURE MEDIUM

IPC classification:
C12N 5/00
Applicant:
Novartis AG
Agent:
Markus Breuer, Henkel Breuer & Partner
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
PATENT GRANTED
EP15829714

MOVING-HORIZON STATE-INITIALIZER FOR CONTROL APPLICATIONS

IPC classification:
A61M 5/172
Applicant:
University of California
Agent:
Markus Breuer, Henkel Breuer & Partner
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature